Institute for International Research

Dear Colleague,

The Institute for International Research is proud to announce the only conference dedicated to understanding how to Incorporate Pharmacogenomics in Clinical Trials.

Currently, 121 marketed drug labels contain pharmacogenomic information and this information is used as a clinical adjunct for selection, dosing of drugs, as well as the assessment drug safety.

As the world of pharmaceutical clinical development constantly evolves with an increased focus on safety and efficacy, it is imperative to develop a pharmacogenomic strategy to improve the likelihood of the success of your clinical trial through a better understanding of the pharmacogenetics of the drug.

This conference is specifically focused on bringing you the most recent case examples and practical tools for developing and validating pharmacogenomics assays, learning from clinical experiences and understanding regulatory guidelines for incorporating pharmacogenomics into your trial. Whether you design clinical trials, develop pharmacogenomic assays, or build strategies to comply with regulatory guidelines for pharmacogenomic data submissions you will benefit from this conference.

This practical conference is dedicated to:
• Understanding clinical experiences
• Assay development & validation
• Gathering & submitting genomic data
• Clarifying regulatory landscape
• Improving safety & efficacy

Join in this practical lessons – learned based conference to establish clear tools for integrating pharmacogenomics into your clinical studies. We look forward to seeing you September 25th at the Hyatt Regency in Baltimore.

Don't miss this exceptional opportunity to learn from a truly distinguished faculty and network with colleagues. Register early, as space is limited. Benefit from our special group discount – send three or more individuals and receive a 15% discount off the registration fee. No two offers can be combined. Register online or, if you prefer, phone us at 888-670-8200 (U.S.) or 941-951-7885 (Int'l), or fax us at 941-365-2507.

Sincerely,

Anne Reel,
Program Director
Pharmaceutical Division, IIR

Valerie Bowling
General Manager
Pharmaceutical Division, IIR